165 related articles for article (PubMed ID: 25244502)
1. Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concerns.
Abdel-Rahman O; ElHalawani H
Expert Opin Drug Saf; 2014 Nov; 13(11):1443-67. PubMed ID: 25244502
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
[TBL] [Abstract][Full Text] [Related]
3. [Adjuvant chemotherapy of early stage breast cancer].
Boér K
Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
[TBL] [Abstract][Full Text] [Related]
5. Target therapy in elderly breast cancer patients.
Carli P; Turchet E; Quitadamo D; Spada A; Miolo G; Lamaj E; Spazzapan S; Di Lauro V; Dolcetti R; Veronesi A; Crivellari D
Crit Rev Oncol Hematol; 2012 Sep; 83(3):422-31. PubMed ID: 22257652
[TBL] [Abstract][Full Text] [Related]
6. [Strategies of breast cancer treatment based on determination of biological subtype].
Semiglazov VF
Vopr Onkol; 2011; 57(5):542-52. PubMed ID: 22238922
[No Abstract] [Full Text] [Related]
7. Advances in the treatment of breast cancer.
Moulder S; Hortobagyi GN
Clin Pharmacol Ther; 2008 Jan; 83(1):26-36. PubMed ID: 18091763
[TBL] [Abstract][Full Text] [Related]
8. Sowing the soil for cure? Results of the ABCSG-12 trial open a new chapter in the evolving adjuvant bisphosphonate story in early breast cancer.
Bedard PL; Body JJ; Piccart-Gebhart MJ
J Clin Oncol; 2009 Sep; 27(25):4043-6. PubMed ID: 19652062
[No Abstract] [Full Text] [Related]
9. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.
Barthélémy P; Heitz D; Mathelin C; Polesi H; Asmane I; Litique V; Rob L; Bergerat JP; Kurtz JE
Crit Rev Oncol Hematol; 2011 Aug; 79(2):196-204. PubMed ID: 20655243
[TBL] [Abstract][Full Text] [Related]
10. An update on adjuvant systemic therapy for elderly patients with early breast cancer.
Jerzak KJ; Desautels DN; Pritchard KI
Expert Opin Pharmacother; 2016 Oct; 17(14):1881-8. PubMed ID: 27539883
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant trastuzumab for breast cancer. Better to stick with proven treatments.
Prescrire Int; 2013 Feb; 22(135):39. PubMed ID: 23444499
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients.
Bastiaannet E; Liefers GJ; de Craen AJ; Kuppen PJ; van de Water W; Portielje JE; van der Geest LG; Janssen-Heijnen ML; Dekkers OM; van de Velde CJ; Westendorp RG
Breast Cancer Res Treat; 2010 Dec; 124(3):801-7. PubMed ID: 20428937
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapies for very young women with early stage breast cancer.
Freedman RA; Partridge AH
Breast; 2011 Oct; 20 Suppl 3():S146-9. PubMed ID: 22015283
[TBL] [Abstract][Full Text] [Related]
14. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
Görner M; Just M; Gerull S
Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
[TBL] [Abstract][Full Text] [Related]
15. HER2-positive breast cancer: current treatment strategies.
Perez EA; Baweja M
Cancer Invest; 2008 Jul; 26(6):545-52. PubMed ID: 18584344
[No Abstract] [Full Text] [Related]
16. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
17. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
Biganzoli L; Aapro M
Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial.
Safra T; Bernstein-Molho R; Greenberg J; Pelles-Avraham S; Stephansky I; Sarid D; Inbar MJ; Stemmer SM; Geffen DB
Oncology; 2011; 81(5-6):298-305. PubMed ID: 22156381
[TBL] [Abstract][Full Text] [Related]
19. Current and future anti-HER2 therapy in breast cancer.
Vrbic S; Pejcic I; Filipovic S; Kocic B; Vrbic M
J BUON; 2013; 18(1):4-16. PubMed ID: 23613383
[TBL] [Abstract][Full Text] [Related]
20. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
Lipton A
Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
